Eli Lilly & Co.

Pharmaceuticals
USA
Revenue (US$ Millions)$9,913
Revenue Growth (%)20.97%
Net Income (US$ Millions)$2,547
Earnings Per Share (US$)$2.30
Total Equity (US$ Millions)$5,013
Profit Margin (%)25.69%
Debt To Equity Ratio (%)0.56%